Was preparing for the launch of their drug into the Rheumatoid Arthritis treatments market and had developed a list of five potential brand names to use across Europe.
Online quantitative interviews (CAWI) lasting 20 mins were conducted with 50 prescribing rheumatologists in each of US, UK, France, Germany, Italy and Spain.
The results of this research enabled the client to establish which of the proposed brand names could be further developed in a subsequent round of research. Additionally it allowed client to see where country differences existed in preference for certain brand names.